Washington SB 5240: Concerning anaphylaxis medications in schools.

Status: By resolution, returned to Senate Rules Committee for third reading. (as of 2026-03-12)

State: Washington · Session: 2025-2026 · Bill: SB 5240

Sponsors: Wellman, Boehnke, C. Wilson, Hasegawa, Nobles, Slatter, Stanford, Trudeau

View Washington SB 5240 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.